Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC -4.26%58 EV-to-EBITDA is 5.26 as of Jul. 26, 2026, which is 40% below its 10-year median of 8.78. GuruFocus rates ASX:AHC with a GF Score™ of 58/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 511 Medical Devices & Instruments companies, Austco Healthcare ranks better than 87.67% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Austco Healthcare's enterprise value is A$73.51 Mil.
Austco Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$13.97 Mil. Therefore, Austco Healthcare's EV-to-EBITDA for today is 5.26.
The historical rank and industry rank for Austco Healthcare's EV-to-EBITDA or its related term are showing as below:
ASX:AHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.9 Med: 8.78 Max: 47.17
Current: 5.26
During the past 13 years, the highest EV-to-EBITDA of Austco Healthcare was 47.17. The lowest was -6.90. And the median was 8.78.
ASX:AHC's EV-to-EBITDA is ranked better than 87.67% of 511
companies
in the Medical Devices & Instruments industry
Industry Median: 14.03
vs ASX:AHC: 5.26
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Austco Healthcare's PE Ratio (TTM) for today is calculated as:
Austco Healthcare's share price for today is A$0.225.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.021.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Austco Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AHC vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Austco Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's EV-to-EBITDA falls into.
Austco Healthcare's current Enterprise Value is A$73.51 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Austco Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$13.97 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a EV-to-EBITDA of 5.26 as of Jul. 26, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Austco Healthcare. This is 40% below median its historical median of 8.78. According to the industry distribution chart, Austco Healthcare ranks #63 out of 511 companies in the Medical Devices & Instruments industry, placing it in the top 12.3%.
Is Austco Healthcare's EV-to-EBITDA too high?
Austco Healthcare's current EV-to-EBITDA of 5.26 is 40% below median its 10-year median of 8.78. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.03. Austco Healthcare's value of 5.26 is 62.5% below this industry median. Based on the distribution chart, Austco Healthcare ranks #63 out of 511 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austco Healthcare has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #63 out of 511 companies for EV-to-EBITDA. This places Austco Healthcare in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.03. Austco Healthcare's value of 5.26 is 62.5% below this benchmark. While the company's 10-year median is 8.78 vs. the industry median of 14.03, Austco Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.03, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current EV-to-EBITDA of 5.26 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Austco Healthcare. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current EV-to-EBITDA is 5.26, which is 40% below median its own 10-year median of 8.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.23 — trading 31.8% below its estimated fair value. The current EV-to-EBITDA is 5.26, which is 40% below median its 10-year median of 8.78 and 62.5% below the Medical Devices & Instruments industry median of 14.03. Austco Healthcare's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current EV-to-EBITDA is 5.26 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.23 is trading 31.8% below its estimated GF Value™ of A$0.33.
GuruFocus considers Austco Healthcare to be Possible Value Trap.
Key valuation signals for ASX:AHC:
EV-to-EBITDA: 5.26 (40% below median its 10-year median of 8.78)
GF Value™: A$0.33 vs. price of A$0.23 (31.8% below fair value)
Industry Position: 62.5% below the Medical Devices & Instruments median (#63 of 511)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
58GF Score
Get the complete analysis for ASX:AHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
